Opioid analgesics and antagonists JH Jaffe The pharmacological basis of therapeutics, 485-521, 1991 | 2134 | 1991 |
Central modulation of pain MH Ossipov, GO Dussor, F Porreca The Journal of clinical investigation 120 (11), 3779-3787, 2010 | 1474 | 2010 |
Chronic pain and medullary descending facilitation F Porreca, MH Ossipov, GF Gebhart Trends in neurosciences 25 (6), 319-325, 2002 | 1191 | 2002 |
Descending pain modulation and chronification of pain MH Ossipov, K Morimura, F Porreca Current opinion in supportive and palliative care 8 (2), 143-151, 2014 | 903 | 2014 |
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids C Wahlestedt, P Salmi, L Good, J Kela, T Johnsson, T Hökfelt, ... Proceedings of the National Academy of Sciences 97 (10), 5633-5638, 2000 | 894 | 2000 |
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids MM Ibrahim, F Porreca, J Lai, PJ Albrecht, FL Rice, A Khodorova, G Davar, ... Proceedings of the National Academy of Sciences 102 (8), 3093-3098, 2005 | 685 | 2005 |
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS MM Ibrahim, H Deng, A Zvonok, DA Cockayne, J Kwan, HP Mata, ... Proceedings of the National Academy of Sciences 100 (18), 10529-10533, 2003 | 614 | 2003 |
Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1. 8 J Lai, MS Gold, CS Kim, D Biana, MH Ossipov, JC Hunterc, F Porreca Pain 95 (1-2), 143-152, 2002 | 609 | 2002 |
Unmasking the tonic-aversive state in neuropathic pain T King, L Vera-Portocarrero, T Gutierrez, TW Vanderah, G Dussor, J Lai, ... Nature neuroscience 12 (11), 1364-1366, 2009 | 597 | 2009 |
Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. F Porreca, HI Mosberg, R Hurst, VJ Hruby, TF Burks Journal of Pharmacology and Experimental Therapeutics 230 (2), 341-348, 1984 | 554 | 1984 |
CB2 cannabinoid receptor-mediated peripheral antinociception TP Malan Jr, MM Ibrahim, H Deng, Q Liu, HP Mata, T Vanderah, F Porreca, ... Pain 93 (3), 239-245, 2001 | 521 | 2001 |
Reward and motivation in pain and pain relief E Navratilova, F Porreca Nature neuroscience 17 (10), 1304-1312, 2014 | 502 | 2014 |
A newly identified role for superoxide in inflammatory pain ZQ Wang, F Porreca, S Cuzzocrea, K Galen, R Lightfoot, E Masini, ... Journal of Pharmacology and Experimental Therapeutics 309 (3), 869-878, 2004 | 495 | 2004 |
Statistical analysis of drug-drug and site-site interactions with isobolograms RJ Tallarida, F Porreca, A Cowan Life sciences 45 (11), 947-961, 1989 | 487 | 1989 |
Redistribution of NaV1. 8 in uninjured axons enables neuropathic pain MS Gold, D Weinreich, CS Kim, R Wang, J Treanor, F Porreca, J Lai Journal of Neuroscience 23 (1), 158-166, 2003 | 478 | 2003 |
The rat paw formalin test: comparison of noxious agents H Wheeler-Aceto, F Porreca, A Cowan Pain 40 (2), 229-238, 1990 | 459 | 1990 |
The role of sodium channels in chronic inflammatory and neuropathic pain R Amir, CE Argoff, GJ Bennett, TR Cummins, ME Durieux, P Gerner, ... The Journal of Pain 7 (5), S1-S29, 2006 | 458 | 2006 |
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2, 3-dihydrobenzo [b][1, 4] dioxin-6-yl) acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties NR Gavva, R Tamir, Y Qu, L Klionsky, TJ Zhang, D Immke, J Wang, D Zhu, ... Journal of Pharmacology and Experimental Therapeutics 313 (1), 474-484, 2005 | 451 | 2005 |
Voltage-gated sodium channels and hyperalgesia J Lai, F Porreca, JC Hunter, MS Gold Annu. Rev. Pharmacol. Toxicol. 44 (1), 371-397, 2004 | 437 | 2004 |
Distinct potassium channels on pain-sensing neurons MN Rasband, EW Park, TW Vanderah, J Lai, F Porreca, JS Trimmer Proceedings of the National Academy of Sciences 98 (23), 13373-13378, 2001 | 437 | 2001 |